Developer docs
API playgroundTry for free, no card

Search company profiles

Astrobiome

Full company profile

uuid0031oco

Namestring
Astrobiome
Legal namestring
Astrobiome Space SARL
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Astrobiome (legal entity: Astrobiome Space SARL) is a privately held biotechnology company founded in 2022, headquartered in Luxembourg with operational presence in Houston. The company develops "Super-Postbiotics" — bioactive metabolite formulations built on bacterial strains sourced from centenarian gut microbiota and millenary olive tree microbiomes, then exposed to space environment conditions (microgravity, radiation) aboard International Space Station missions. The platform combines Japanese fermentation mastery with space biotechnology and is underpinned by 25 years of microbiome evolution research inherited from Innovation Labo Sciences.

The company operates three commercial lines: (1) a direct-to-consumer postbiotic supplement business sold through owned e-commerce (astrobiome.space, shop.astrobiome.space) at $195–$245 per month on subscription and $245 / $700 / $2,100 for one-time purchases; (2) a B2B ingredient licensing platform branded "Astrobiome INSIDE," targeting functional beverage and snack brands; and (3) a Beyond Organic agricultural biostimulant positioned in the ag-biotech segment at $250 per unit. The reported output is 300+ bioactive metabolites per formulation.

Astrobiome has assembled a multi-agency space ecosystem — partnerships with NASA, JAXA, ESA, and the Luxembourg Space Agency (including two LuxImpulse grants in 2025 and 2026), and a flagship ISS Commercial Greenhouse mission with Redwire Corporation scheduled for June 2026. The company has won industry recognition annually since 2022, including NutraIngredients Start-up of the Year (2022), the ESA Space Impact Hall of Fame (2023), Top Agri Biotech Solutions Provider (2024), and Most Innovative Microbiome Therapeutics Company from Global Health & Pharma (2025). It hosted the Astrobiome Space Symposium at the Osaka World Expo, indicating Japan/APAC market intent. Founder and CEO Vera Mulyani and Chief Scientist Dr. Bejit Ideas lead the company.

Short descriptiontext

Astrobiome is a Luxembourg-based biotechnology company that develops space-adapted postbiotic supplements, B2B functional ingredients, and agricultural biostimulants from bacterial strains exposed to microgravity aboard the International Space Station. It serves health-conscious consumers, food and beverage brands, and the ag-biotech sector.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLuxembourg, Luxembourg
HQ citystring
Luxembourg
HQ countrystring
Luxembourg
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
postbiotic supplements, microbiome therapeutics, space biotechnology, agricultural biostimulants, ingredient licensing
Industry4 codes
PRIMARYHLAAAFAB
Microbiome-Derived Metabolite Therapeutics (postbiotics)
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYAFAJAJAE
Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Medicinal Chemicals & Botanical Products2833
Product category
Postbiotic Supplements
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Consumer Supplements
TypeSubscription Recurring
Description

Direct-to-consumer sale of postbiotic supplements in capsule form with subscription and one-time purchase options. Products include 1-month, 3-month, and 1-year treatment packages.

astrobiome.space
2B2B Ingredient Platform (Astrobiome INSIDE)
TypeLicensing Royalties
Description

Licensing/supply of postbiotic metabolites as an advanced ingredient platform for functional beverages, snacks, and children's drinks. Brands can integrate bioactive metabolites without altering taste, texture, or stability.

astrobiome.space
3Agricultural Biostimulant
TypeOne Time License
Description

Sale of Beyond Organic Biostimulant for plants, derived from space-adapted microbes for soil enhancement applications.

astrobiome.space
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details5 tiers
11 Month Treatment - Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

$195/month (sale price) or $245/month (original price) for monthly subscription

astrobiome.space
21 Month Treatment - One-time
ModelOne time/ perpetual licenseBilling cadenceMonthly
Notes

$245 one-time purchase

astrobiome.space
33 Month Treatment
ModelOne time/ perpetual licenseBilling cadenceMonthly
Notes

$700 for 3-month supply

astrobiome.space
41 Year Family Package
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

$2,100 for 1-year supply (12 months)

astrobiome.space
5Beyond Organic Biostimulant for Plants
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$250 per unit for agricultural soil enhancement product

astrobiome.space
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Astrobiome® INSIDE
Description

An advanced ingredient platform designed to elevate functional beverages and snacks with bioactive metabolites, available in liquid or powder form for brand integration.

astrobiome.space
+1 more record
Core offering1 text field

Astrobiome produces Super-Postbiotics through a proprietary space-adapted microbiome platform that ferments bacterial strains under microgravity and radiation conditions, generating over 300 bioactive metabolites. The company sells consumer postbiotic supplement capsules directly via its e-commerce storefront and licenses its postbiotic metabolite ingredient to food and beverage brands through the Astrobiome INSIDE B2B platform. It also markets a Beyond Organic Biostimulant for agricultural soil enhancement derived from space-adapted microbes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Blood sugar reduction in Type 2 diabetes patients within 3 days of use
+3 more records
Product overview1 text field

Astrobiome is a Luxembourg-based biotechnology company that produces Super-Postbiotics™ through a unique process combining Japanese fermentation mastery with space biotechnology. The product portfolio centers on the core Astrobiome® Postbiotics line—daily supplement capsules available in 1-month, 3-month, and 1-year treatment packages (plus subscription options)—containing over 300 bioactive metabolites derived from space-adapted bacterial strains. The company also offers Astrobiome® INSIDE, an ingredient platform enabling third-party brands to integrate these postbiotic compounds into functional beverages and snacks. A complementary product, Beyond Organic Biostimulant® for Plants, applies the company's space-adapted microbe technology to agricultural biostimulants. The products are positioned around microbiome health, longevity, and resilience, derived from strains modeled on super-centenarians and evolved under space conditions.

Product and service6 records
1Astrobiome Postbiotics Capsules (1-Month Treatment)
CategoryPostbiotic Dietary Supplements
Description

Daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Available as a 1-month treatment package for individual consumers seeking gut health, immune, and longevity support.

2Astrobiome Postbiotics Capsules (3-Month Treatment)
CategoryPostbiotic Dietary Supplements
Description

Three-month supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Marketed for sustained microbiome balance, digestive health, and whole-body resilience.

3Astrobiome Postbiotics Capsules (1-Year Family Package)
CategoryPostbiotic Dietary Supplements
Description

One-year (12-month) supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites, sold as a Family Package for households seeking long-term longevity, vitality, and optimized metabolic support.

4Astrobiome Postbiotics Monthly Subscription
CategoryPostbiotic Dietary Supplements
Description

Recurring monthly subscription to Astrobiome Postbiotics capsules at a discounted price versus one-time purchase, with automatic ongoing delivery for consumer convenience.

5Astrobiome INSIDE (B2B Ingredient Platform)
CategoryB2B Ingredient Platform / Functional Nutrition
Description

Advanced ingredient platform supplying postbiotic metabolites in liquid or powder form to functional beverage, snack, and children's drink manufacturers, enabling integration of gut-health and longevity benefits without altering taste, texture, or stability.

6Beyond Organic Biostimulant for Plants
CategoryAgricultural Biostimulant
Description

Plant biostimulant developed from space-adapted microbes for agricultural soil enhancement applications, including strawberry cultivation in space environments, leveraging the company's microgravity-adapted microorganisms.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-04
Description

Astrobiome signed contract with Redwire Corporation on June 4, 2026 to launch commercial Greenhouse system aboard the International Space Station for space agriculture research. The mission will grow wild strawberries and test Astrobiome's proprietary soil enhancement biostimulant developed from space-adapted microbes. This marks the world's first commercial space greenhouse, driving significant investor interest and 12-18% stock surge for Redwire.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Luxembourg Space Agency supports Astrobiome through LuxImpulse grants. Mathias Link, Deputy Director General, highlighted international collaboration with NASA, JAXA, ESA and emphasized how the mission brings together space exploration, agriculture, food security and health with significant commercial opportunities.

3Innovation Labo Sciences, Ltd
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Japan-based microbiome research laboratory. Dr. Bejit Ideas serves as Chief Scientist at Astrobiome Space and inventor at Innovation Labo Sciences. The partnership draws on 25 years of microbiome evolution research conducted at Innovation Labo, the world's first research platform for co-culturing bacteria in extreme environments.

astrobiome.space
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-organizer of Astrobiome Space Symposium at the French Pavilion during Osaka World Expo, collaborating with Astrobiome Space SARL and Innovation Labo Sciences on space medicine and longevity microbiome research presentations.

5NASA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with NASA for space biotechnology development. Dr. Jennifer Fogarty, former Chief Scientist of NASA's Human Research Program, participated in Astrobiome Space Symposium. The collaboration enables formulation of postbiotic solutions with exceptional efficacy for space and terrestrial applications.

astrobiome.space
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for space-based microbiome studies. Astronaut Soichi Noguchi, former JAXA astronaut, shared insights from multiple missions and emphasized urgent need for microbial solutions to support long-duration space missions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ESA collaboration recognized through Space Impact Hall of Fame award. ESA supports space-based research initiatives that enable Astrobiome's unique production process using microgravity conditions.

Strategic tierMinorTypeGTM or Marketing Partner
Description

David Merle, CEO of Bonneval Waters, presented at Astrobiome Space Symposium on applying innovative technology to beverages, highlighting potential for integrating advanced microbiological solutions into energy drinks for enhanced health benefits.

9L'Osier Restaurant (Tokyo)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Chef Olivier Chaignon, Executive Chef of 3 Michelin-starred L'Osier, presented concept of microbiological agriculture as new frontier in gastronomy, showing how ingredients cultivated in microbiome-rich environments can enhance nutritional and sensory quality.

astrobiome.space
10Chocolkan Brain Longevity
Strategic tierMinorTypeGTM or Marketing Partner
Description

Sophie Burrus-Müller, creator of Chocolkan Brain Longevity project, developed dairy-free chocolate drink for memory improvement and brain cell repair using postbiotic integration concepts presented at symposium.

astrobiome.space
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based probiotics and microbiome science company selling DTC synbiotic/postbiotic supplements. Comparable target customer (wellness-optimized consumer), premium pricing model, and science-led brand storytelling, with an emerging ingredient platform serving clinical and nutrition partners.

TypeBroad incumbent
Description

Global bioscience major (formed via Novozymes and Chr. Hansen merger) producing food cultures, enzymes, and probiotic/postbiotic ingredients for B2B food, beverage, nutrition, and agriculture markets. Directly comparable to Astrobiome INSIDE on the B2B ingredient side and able to scale postbiotic licensing far beyond what a sub-50-employee startup can serve.

3Lallemand Health Solutions
TypeBroad incumbent
Description

Canadian-owned global supplier of probiotic and postbiotic ingredients for human and animal nutrition. Comparable as a B2B probiotic/postbiotic fermentation platform serving supplement and F&B brands, with established documentation and regulatory frameworks Astrobiome currently lacks.

TypeEmerging player
Description

Spain-based probiotics and microbiome ingredient company with proprietary strains and clinical dossiers. Comparable on B2B probiotic ingredient licensing to F&B and supplement brands, and on strain-engineering focus.

TypeEmerging player
Description

US-based postbiotic personal care and ingestible brand developed from microbiome research. Comparable as a consumer-facing brand built around postbiotic/fermentation-derived bioactives, with premium positioning and category-creation ambitions similar to Astrobiome's.

TypeBroad incumbent
Description

Legacy probiotic and food-cultures giant (merged into Novonesis) with deep pipeline of human and animal probiotic/postbiotic strains. Comparable on fermentation science, strains derived from human microbiota, and B2B ingredient licensing model.

TypeEmerging player
Description

US-based agricultural microbiome company producing microbial nitrogen-fixing biostimulants for crops. Comparable to Astrobiome's Beyond Organic Biostimulant product on agricultural biostimulant positioning and microbial-input technology, and a credible test case for scaling biological ag inputs to mainstream growers.

TypeDirect peer
Description

US-based microbiome supplement company offering probiotics, prebiotics, and postbiotic-style digestive formulations. Comparable in product form (capsules), consumer positioning (gut health, weight management), and emphasis on full-spectrum microbiome science.

TypeDirect peer
Description

US-based DTC microbiome/postbiotic supplement company selling glucose control, metabolic, and gut health products. Closest direct competitor to Astrobiome's capsule-based postbiotic portfolio with similar premium DTC positioning and digestive/metabolic efficacy claims.

TypeEmerging player
Description

Microbiome company translating elite-athlete microbiome research into consumer gut health products. Comparable in microbiome-derived bioactive positioning and use of proprietary strains, though narrower in product scope than Astrobiome's full-spectrum metabolite complex.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Astrobiome

Postbiotic Supplementsastrobiome.space

Astrobiome is a Luxembourg-based biotechnology company that develops space-adapted postbiotic supplements, B2B functional ingredients, and agricultural biostimulants from bacterial strains exposed to microgravity aboard the International Space Station. It serves health-conscious consumers, food and beverage brands, and the ag-biotech sector.

What Astrobiome does

Astrobiome (legal entity: Astrobiome Space SARL) is a privately held biotechnology company founded in 2022, headquartered in Luxembourg with operational presence in Houston. The company develops "Super-Postbiotics" — bioactive metabolite formulations built on bacterial strains sourced from centenarian gut microbiota and millenary olive tree microbiomes, then exposed to space environment conditions (microgravity, radiation) aboard International Space Station missions. The platform combines Japanese fermentation mastery with space biotechnology and is underpinned by 25 years of microbiome evolution research inherited from Innovation Labo Sciences.

The company operates three commercial lines: (1) a direct-to-consumer postbiotic supplement business sold through owned e-commerce (astrobiome.space, shop.astrobiome.space) at $195–$245 per month on subscription and $245 / $700 / $2,100 for one-time purchases; (2) a B2B ingredient licensing platform branded "Astrobiome INSIDE," targeting functional beverage and snack brands; and (3) a Beyond Organic agricultural biostimulant positioned in the ag-biotech segment at $250 per unit. The reported output is 300+ bioactive metabolites per formulation.

Astrobiome has assembled a multi-agency space ecosystem — partnerships with NASA, JAXA, ESA, and the Luxembourg Space Agency (including two LuxImpulse grants in 2025 and 2026), and a flagship ISS Commercial Greenhouse mission with Redwire Corporation scheduled for June 2026. The company has won industry recognition annually since 2022, including NutraIngredients Start-up of the Year (2022), the ESA Space Impact Hall of Fame (2023), Top Agri Biotech Solutions Provider (2024), and Most Innovative Microbiome Therapeutics Company from Global Health & Pharma (2025). It hosted the Astrobiome Space Symposium at the Osaka World Expo, indicating Japan/APAC market intent. Founder and CEO Vera Mulyani and Chief Scientist Dr. Bejit Ideas lead the company.

Astrobiome firmographics

Firmographics
Name
Astrobiome
Legal name
Astrobiome Space SARL
Website
https://astrobiome.space
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Astrobiome is a Luxembourg-based biotechnology company that develops space-adapted postbiotic supplements, B2B functional ingredients, and agricultural biostimulants from bacterial strains exposed to microgravity aboard the International Space Station. It serves health-conscious consumers, food and beverage brands, and the ag-biotech sector.
Ownership category
akta.pro rank

Astrobiome industry classification

Industry
Product category
Postbiotic Supplements
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAAAFAB
Microbiome-Derived Metabolite Therapeutics (postbiotics)
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYAFAJAJAE
Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)

Keywords

  • Postbiotic supplements
  • Microbiome therapeutics
  • Space biotechnology
  • Agricultural biostimulants
  • Ingredient licensing

Where Astrobiome is headquartered

Location

Headquarters

HQ city
Luxembourg
HQ country
Luxembourg
HQ region
Europe

Offices1 record

Markets served

Astrobiome business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Consumer Supplements: Direct-to-consumer sale of postbiotic supplements in capsule form with subscription and one-time purchase options. Products include 1-month, 3-month, and 1-year treatment packages.
  2. B2B Ingredient Platform (Astrobiome INSIDE): Licensing/supply of postbiotic metabolites as an advanced ingredient platform for functional beverages, snacks, and children's drinks. Brands can integrate bioactive metabolites without altering taste, texture, or stability.
  3. Agricultural Biostimulant: Sale of Beyond Organic Biostimulant for plants, derived from space-adapted microbes for soil enhancement applications.

Pricing tiers

ModelBillingPrice
SubscriptionMonthly1 Month Treatment - Subscription
One time/ perpetual licenseMonthly1 Month Treatment - One-time
One time/ perpetual licenseMonthly3 Month Treatment
One time/ perpetual licenseMulti-year contract1 Year Family Package
Unit PricingPay-as-you-goBeyond Organic Biostimulant for Plants

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Astrobiome product offering

Product offering

Core offering

Astrobiome produces Super-Postbiotics through a proprietary space-adapted microbiome platform that ferments bacterial strains under microgravity and radiation conditions, generating over 300 bioactive metabolites. The company sells consumer postbiotic supplement capsules directly via its e-commerce storefront and licenses its postbiotic metabolite ingredient to food and beverage brands through the Astrobiome INSIDE B2B platform. It also markets a Beyond Organic Biostimulant for agricultural soil enhancement derived from space-adapted microbes.

Product overview

Astrobiome is a Luxembourg-based biotechnology company that produces Super-Postbiotics™ through a unique process combining Japanese fermentation mastery with space biotechnology. The product portfolio centers on the core Astrobiome® Postbiotics line—daily supplement capsules available in 1-month, 3-month, and 1-year treatment packages (plus subscription options)—containing over 300 bioactive metabolites derived from space-adapted bacterial strains. The company also offers Astrobiome® INSIDE, an ingredient platform enabling third-party brands to integrate these postbiotic compounds into functional beverages and snacks. A complementary product, Beyond Organic Biostimulant® for Plants, applies the company's space-adapted microbe technology to agricultural biostimulants. The products are positioned around microbiome health, longevity, and resilience, derived from strains modeled on super-centenarians and evolved under space conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • Astrobiome® INSIDE: An advanced ingredient platform designed to elevate functional beverages and snacks with bioactive metabolites, available in liquid or powder form for brand integration.
  • Super-Postbiotics™

Products and services

  • Astrobiome Postbiotics Capsules (1-Month Treatment) Daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Available as a 1-month treatment package for individual consumers seeking gut health, immune, and longevity support.
  • Astrobiome Postbiotics Capsules (3-Month Treatment) Three-month supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites produced through space-adapted bacterial fermentation. Marketed for sustained microbiome balance, digestive health, and whole-body resilience.
  • Astrobiome Postbiotics Capsules (1-Year Family Package) One-year (12-month) supply of daily postbiotic supplement capsules containing over 300 bioactive metabolites, sold as a Family Package for households seeking long-term longevity, vitality, and optimized metabolic support.
  • Astrobiome Postbiotics Monthly Subscription Recurring monthly subscription to Astrobiome Postbiotics capsules at a discounted price versus one-time purchase, with automatic ongoing delivery for consumer convenience.
  • Astrobiome INSIDE (B2B Ingredient Platform) Advanced ingredient platform supplying postbiotic metabolites in liquid or powder form to functional beverage, snack, and children's drink manufacturers, enabling integration of gut-health and longevity benefits without altering taste, texture, or stability.
  • Beyond Organic Biostimulant for Plants Plant biostimulant developed from space-adapted microbes for agricultural soil enhancement applications, including strawberry cultivation in space environments, leveraging the company's microgravity-adapted microorganisms.

Quantifiable outcome

  • Blood sugar reduction in Type 2 diabetes patients within 3 days of use
  • +3 more outcomes

Companies that use Astrobiome

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Astrobiome technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Astrobiome partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

  • Redwire CorporationflagshipStrategic or Co-development Partner · 4 June 2026Astrobiome signed contract with Redwire Corporation on June 4, 2026 to launch commercial Greenhouse system aboard the International Space Station for space agriculture research. The mission will grow wild strawberries and test Astrobiome's proprietary soil enhancement biostimulant developed from space-adapted microbes. This marks the world's first commercial space greenhouse, driving significant investor interest and 12-18% stock surge for Redwire.
  • Luxembourg Space Agency (LSA)coreStrategic or Co-development PartnerLuxembourg Space Agency supports Astrobiome through LuxImpulse grants. Mathias Link, Deputy Director General, highlighted international collaboration with NASA, JAXA, ESA and emphasized how the mission brings together space exploration, agriculture, food security and health with significant commercial opportunities.
  • Innovation Labo Sciences, LtdcoreStrategic or Co-development PartnerJapan-based microbiome research laboratory. Dr. Bejit Ideas serves as Chief Scientist at Astrobiome Space and inventor at Innovation Labo Sciences. The partnership draws on 25 years of microbiome evolution research conducted at Innovation Labo, the world's first research platform for co-culturing bacteria in extreme environments.
  • NinapharmcoreStrategic or Co-development PartnerCo-organizer of Astrobiome Space Symposium at the French Pavilion during Osaka World Expo, collaborating with Astrobiome Space SARL and Innovation Labo Sciences on space medicine and longevity microbiome research presentations.
  • NASAcoreStrategic or Co-development PartnerResearch collaboration with NASA for space biotechnology development. Dr. Jennifer Fogarty, former Chief Scientist of NASA's Human Research Program, participated in Astrobiome Space Symposium. The collaboration enables formulation of postbiotic solutions with exceptional efficacy for space and terrestrial applications.
  • JAXA (Japan Aerospace Exploration Agency)coreStrategic or Co-development PartnerResearch partnership for space-based microbiome studies. Astronaut Soichi Noguchi, former JAXA astronaut, shared insights from multiple missions and emphasized urgent need for microbial solutions to support long-duration space missions.
  • European Space Agency (ESA)coreStrategic or Co-development PartnerESA collaboration recognized through Space Impact Hall of Fame award. ESA supports space-based research initiatives that enable Astrobiome's unique production process using microgravity conditions.
  • Bonneval WatersminorGTM or Marketing PartnerDavid Merle, CEO of Bonneval Waters, presented at Astrobiome Space Symposium on applying innovative technology to beverages, highlighting potential for integrating advanced microbiological solutions into energy drinks for enhanced health benefits.
  • L'Osier Restaurant (Tokyo)minorGTM or Marketing PartnerChef Olivier Chaignon, Executive Chef of 3 Michelin-starred L'Osier, presented concept of microbiological agriculture as new frontier in gastronomy, showing how ingredients cultivated in microbiome-rich environments can enhance nutritional and sensory quality.
  • Chocolkan Brain LongevityminorGTM or Marketing PartnerSophie Burrus-Müller, creator of Chocolkan Brain Longevity project, developed dairy-free chocolate drink for memory improvement and brain cell repair using postbiotic integration concepts presented at symposium.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Astrobiome competitors and assessment

Company assessment

Direct peers

  • Seed Health: US-based probiotics and microbiome science company selling DTC synbiotic/postbiotic supplements. Comparable target customer (wellness-optimized consumer), premium pricing model, and science-led brand storytelling, with an emerging ingredient platform serving clinical and nutrition partners.
  • BIOHM Health: US-based microbiome supplement company offering probiotics, prebiotics, and postbiotic-style digestive formulations. Comparable in product form (capsules), consumer positioning (gut health, weight management), and emphasis on full-spectrum microbiome science.
  • Pendulum: US-based DTC microbiome/postbiotic supplement company selling glucose control, metabolic, and gut health products. Closest direct competitor to Astrobiome's capsule-based postbiotic portfolio with similar premium DTC positioning and digestive/metabolic efficacy claims.

Broad incumbents

  • Novonesis: Global bioscience major (formed via Novozymes and Chr. Hansen merger) producing food cultures, enzymes, and probiotic/postbiotic ingredients for B2B food, beverage, nutrition, and agriculture markets. Directly comparable to Astrobiome INSIDE on the B2B ingredient side and able to scale postbiotic licensing far beyond what a sub-50-employee startup can serve.
  • Lallemand Health Solutions: Canadian-owned global supplier of probiotic and postbiotic ingredients for human and animal nutrition. Comparable as a B2B probiotic/postbiotic fermentation platform serving supplement and F&B brands, with established documentation and regulatory frameworks Astrobiome currently lacks.
  • Chr. Hansen (now Novonesis): Legacy probiotic and food-cultures giant (merged into Novonesis) with deep pipeline of human and animal probiotic/postbiotic strains. Comparable on fermentation science, strains derived from human microbiota, and B2B ingredient licensing model.

Emerging players

  • AB Biotics: Spain-based probiotics and microbiome ingredient company with proprietary strains and clinical dossiers. Comparable on B2B probiotic ingredient licensing to F&B and supplement brands, and on strain-engineering focus.
  • Symbiome: US-based postbiotic personal care and ingestible brand developed from microbiome research. Comparable as a consumer-facing brand built around postbiotic/fermentation-derived bioactives, with premium positioning and category-creation ambitions similar to Astrobiome's.
  • Pivot Bio: US-based agricultural microbiome company producing microbial nitrogen-fixing biostimulants for crops. Comparable to Astrobiome's Beyond Organic Biostimulant product on agricultural biostimulant positioning and microbial-input technology, and a credible test case for scaling biological ag inputs to mainstream growers.
  • Fitbiomics: Microbiome company translating elite-athlete microbiome research into consumer gut health products. Comparable in microbiome-derived bioactive positioning and use of proprietary strains, though narrower in product scope than Astrobiome's full-spectrum metabolite complex.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Astrobiome social profiles

Digital presence

Astrobiome financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Astrobiome leadership team

Management profile

Number of profiles

Profiles2 records

Astrobiome funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Astrobiome M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Astrobiome

What does Astrobiome do?

Astrobiome produces Super-Postbiotics through a proprietary space-adapted microbiome platform that ferments bacterial strains under microgravity and radiation conditions, generating over 300 bioactive metabolites. The company sells consumer postbiotic supplement capsules directly via its e-commerce storefront and licenses its postbiotic metabolite ingredient to food and beverage brands through the Astrobiome INSIDE B2B platform. It also markets a Beyond Organic Biostimulant for agricultural soil enhancement derived from space-adapted microbes.

Is Astrobiome a public or private company?

Astrobiome is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Astrobiome founded?

Astrobiome was founded in 2022. It employs 1 to 10 people.

Where is Astrobiome based?

Astrobiome is headquartered in Luxembourg, Luxembourg, in the Europe region.

How does Astrobiome make money?

Three revenue lines are on record. Consumer Supplements are the primary driver. The others are B2B Ingredient Platform (Astrobiome INSIDE) and agricultural Biostimulant.

Who are Astrobiome's main competitors?

Direct peers on record are Seed Health, BIOHM Health and Pendulum. Broad incumbents are Novonesis, Lallemand Health Solutions and Chr. Hansen (now Novonesis). Emerging players are AB Biotics, Symbiome, Pivot Bio and Fitbiomics.

Does Astrobiome have an API?

No public API is recorded for Astrobiome.

What industry is Astrobiome in?

Astrobiome's product category is Postbiotic Supplements. Its primary akta.pro industry code is HLAAAFAB, Microbiome-Derived Metabolite Therapeutics (postbiotics), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Insider Trading & Hedge Fund DataRedwire Corporation (RDW) Awards Contract to Deliver Penguin Mk2.5 UAS to Taiwan Coast Guard - Insider MonkeyRedwire Corporation announced on June 30 that it won a contract from Taiwan Color Optics, a subsidiary of SemiLux International, to supply its Penguin Mk2.5 VTOL Uncrewed Aerial System to the Taiwan Coast Guard for maritime security and defense planning. Co-President Josh Stinson highlighted the aircraft's all-weather intelligence and reconnaissance capabilities for coastal monitoring. The company also separately secured a contract from Astrobiome Space on June 4 to launch its commercial Greenhouse system aboard the International Space Station for space agriculture research.Ipo-edgeSpace Farming Takes Off: Redwire Wins Landmark Mission – IPO EdgeRedwire Corp. said its contract with Astrobiome Space will grow strawberries and test biostimulants on the ISS, marking the first flight of its greenhouse system and the world's first commercial space greenhouse. The company expects the wild strawberries to approach Earth-grown quality, supporting long-duration missions and future habitats.BenzingaWhy Is Redwire Stock Soaring Thursday? - Redwire (NYSE:RDW)Redwire Corporation announced it secured a contract from Astrobiome Space to conduct the first mission aboard its commercial space greenhouse on the International Space Station, sending Redwire shares nearly 16% higher. The mission will test Astrobiome Space's microbial biostimulant while growing wild strawberries in orbit, marking the first cultivation of the fruit in space, with Astrobiome Space beginning Earth-based testing this month ahead of the ISS flight. The stock surge was amplified by short covering, with approximately 17.96% of Redwire's public float sold short, though it followed a sharp 15% pullback earlier in the week following a Jefferies downgrade.